Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication

Remdesivir is a nucleoside analog approved by the US FDA for treatment of COVID-19. Here, we present a 3.9-Å-resolution cryo-EM reconstruction of a remdesivir-stalled RNA-dependent RNA polymerase complex, revealing full incorporation of 3 copies of remdesivir monophosphate (RMP) and a partially inco...

Descripción completa

Detalles Bibliográficos
Autores principales: Bravo, Jack P.K., Dangerfield, Tyler L., Taylor, David W., Johnson, Kenneth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Short Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843106/
https://www.ncbi.nlm.nih.gov/pubmed/33631104
http://dx.doi.org/10.1016/j.molcel.2021.01.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843106/
https://www.ncbi.nlm.nih.gov/pubmed/33631104
http://dx.doi.org/10.1016/j.molcel.2021.01.035

Ejemplares similares